Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Aclaris Therapeutics, Inc. | 109,125 | reported | 01 May 2026 | tx 7+1,133,275−45,705 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 May 2026 | EXERCISE | Aclaris Therapeutics, Inc. | 36,375 | — | |
| 01 May 2026 | TAX_WITHHOLDING | Aclaris Therapeutics, Inc. | 9,330 | 4.41 USD | |
| 01 May 2026 | EXERCISE | Aclaris Therapeutics, Inc. | 36,375 | 0.00 USD | deriv |
| 02 Feb 2026 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 343,300 | 0.00 USD | deriv |
| 02 Feb 2026 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 98,100 | 0.00 USD | deriv |
| 01 May 2025 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 145,500 | 0.00 USD | deriv |
| 01 May 2025 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 510,000 | 0.00 USD | deriv |